Skip to main content

Table 3 Components of the maternal and fetal composite outcomes

From: Development and validation of prediction models for risk of adverse outcomes in women with early-onset pre-eclampsia: protocol of the prospective cohort PREP study

Outcome

Definition

Maternal outcomes

 Mortality

Maternal death at any time in pregnancy after delivery until discharge

 Hepatic dysfunction

INR >1.2 indicative of DIC in the absence of treatment with warfarin. (DIC is defined as having both abnormal bleeding and consumptive coagulopathy (i.e. low platelets, abnormal peripheral blood film, or one or more of the following: increased INR, increased PTT, low fibrinogen, of increased fibrin degradation products that are outside normal non-pregnancy ranges).)

 Hepatic haematoma or rupture

Blood collection under the hepatic capsule as confirmed by ultrasound or laparotomy

 Glasgow coma score <13

From the GCS scoring system [39]

 Stroke

Acute neurological event with deficits lasting longer than 48 h

 Cortical blindness

Loss of visual acuity in the presence of intact papillary response to light

 RIND

Cerebral ischaemia lasting longer than 24 h but less than 48 h revealed through clinical examination

 Retinal detachment

Separation of the inner layers of the retina from the underlying RPE (choroid) and is diagnosed by ophthalmological examination

 Acute renal insufficiency

For women with an underlying history of renal disease: defined as creatinine >200 μM; for patients with no underlying renal disease: defined as creatinine >150 μM

 Dialysis

Including haemodialysis and peritoneal dialysis

 Transfusion of blood products

Includes transfusion of any units of blood products: FFP, platelets, RBCs, cryo or whole blood

 Positive ionotropic support

The use of vasopressors to maintain a systolic blood pressure >90 mmHg or mean arterial pressure >70 mmHg

 Myocardial ischaemia/infarction

ECG changes (ST segment elevation or depression) without enzyme changes and/or any one of the following: (1) development of new pathologic Q waves on serial ECGs. The patient may or may not remember previous symptoms. Biochemical markers of myocardial necrosis may have normalised, depending on the length of time that has passed since the infarct developed. (2) Pathological findings of an acute, healed or healing MI. (3) Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one of the following: (a) ischaemic symptoms; (b) development of pathologic Q waves on the ECG; (c) ECG changes indicative of ischaemia (ST segment elevation or depression) or (d) coronary artery intervention (e.g. coronary angioplasty)

 Require >50% oxygen for greater than 1 h

Oxygen given at greater than 50% concentration based on local criteria for longer than 1 h

 Intubation other than for caesarean section

Intubation maybe by ventilation, electrical impedance tomography or continuous positive airway pressure

 Pulmonary oedema

Clinical diagnosis with x-ray confirmation or requirement of diuretic treatment and SaO2 <94%

 Postpartum haemorrhage

>1 L of blood loss after delivery

 Early preterm delivery

Delivery at gestational age of less than 34 weeks

Fetal outcomes

 Perinatal or infant mortality

Death of a fetus or neonate. Infant mortality is the death of a child less than 1 year of age

 Bronchopulmonary dysplasia

Oxygen requirement at 36 weeks’ corrected gestation unrelated to an acute respiratory episode

 Necrotising enterocolitis including only Bell’s stage 2 or 3

Evidence of pneumotosis intestinalis on abdominal x-ray and/or surgical intervention

 Grade III/IV intraventricular haemorrhage

Bleeding into the brain’s ventricular system, where the ventricles are enlarged by the accumulated blood or bleeding extends into the brain tissue around the ventricles

 Cystic periventricular leukomalacia

Softening and necrosis in the hemispheric white matter in newborns that may result from impaired perfusion at the interface between the ventriculopetal and ventriculofugal arteries

 Stage 3–5 retinopathy of prematurity

Abnormal blood vessel development in the retina of the eye, where blood vessel growth is severely abnormal, where there is a partially or totally detached retina

 Hypoxic ischaemic encephalopathy

Apgar score ≤5 at 10 min and/or pH 7.00 in the first 60 min of life and/or base deficit ≥−16 in the first 60 min associated with an abnormal consciousness level (lethargy, stupor or coma) and seizures and/or poor/weak suck and/or hypotonia and/or abnormal reflexes

  1. Adapted from the PIERS study
  2. INR international normalised ratio, DIC disseminated intravascular coagulation, PTT partial thromboplastin time, GCS Glasgow Coma Scale, RIND reversible ischaemic neurologic deficit, RPE retinal pigment epithelium, FFP fresh frozen plasma, RBCs red blood cells, cryo cryoprecipitate, ECG electrocardiography